DNA Vaccination Against Cholesterol Ester Transfer Protein in the Treatment of Atherosclerosis
A Standard patent application filed on 17 December 2002 credited to Needleman, Philip
;
Glenn, Kevin
Details
Application number :
2002318783
Application type :
Standard
Application status :
LAPSED
Under opposition :
No
Proceeding type :
Invention title :
DNA Vaccination Against Cholesterol Ester Transfer Protein in the Treatment of Atherosclerosis
Inventor :
Needleman, Philip
;
Glenn, Kevin
Agent name :
EF WELLINGTON & CO
Address for service :
312 St. Kilda Road Southbank Melbourne VIC 3006 Australia
Filing date :
17 December 2002
Associated companies :
Applicant name :
Avant Immunotherapeutics Inc.
Applicant address :
119 Fourth Avenue Needham Massachusetts 02494 United States of America